Carica papaya Leaves Juice Significantly Accelerates the Rate of Increase in Platelet Count among Patients with Dengue Fever and Dengue Haemorrhagic Fever

Soobitha Subenthiran, Tan Chwee Choon, Kee Chee Cheong, Ravindran Thayan, Mok Boon Teck, Prem Kumar Muniandy, Adlin Afzan, Noor Rain Abdullah, Zakiah Ismail, Soobitha Subenthiran, Tan Chwee Choon, Kee Chee Cheong, Ravindran Thayan, Mok Boon Teck, Prem Kumar Muniandy, Adlin Afzan, Noor Rain Abdullah, Zakiah Ismail

Abstract

The study was conducted to investigate the platelet increasing property of Carica papaya leaves juice (CPLJ) in patients with dengue fever (DF). An open labeled randomized controlled trial was carried out on 228 patients with DF and dengue haemorrhagic fever (DHF). Approximately half the patients received the juice, for 3 consecutive days while the others remained as controls and received the standard management. Their full blood count was monitored 8 hours for 48 hours. Gene expression studies were conducted on the ALOX 12 and PTAFR genes. The mean increase in platelet counts were compared in both groups using repeated measure ANCOVA. There was a significant increase in mean platelet count observed in the intervention group (P < 0.001) but not in the control group 40 hours since the first dose of CPLJ. Comparison of mean platelet count between intervention and control group showed that mean platelet count in intervention group was significantly higher than control group after 40 and 48 hours of admission (P < 0.01). The ALOX 12 (FC = 15.00) and PTAFR (FC = 13.42) genes were highly expressed among those on the juice. It was concluded that CPLJ does significantly increase the platelet count in patients with DF and DHF.

Figures

Figure 1
Figure 1
Comparison of mean platelet count between intervention and control group based on time (time-treatment effect).

References

    1. Burkill IH. A Dictionary of the Economic Products of the Malay Peninsula. Vol. 1. London, UK: The Crown Agents for the Colonies; 1935.
    1. Arumuganathan K, Earle ED. Nuclear DNA content of some important plant species. Plant Molecular Biology Reporter. 1991;9(3):208–218.
    1. FAOSTAT:Papaya marketing-general information. GFruit Web site, 2012, .
    1. Villegas VN. Carica papaya L. In: Verheij EMW, Coronel RE, editors. Plant Resources of South-East Asia 2: Edible Fruits and Nuts. Vol. 2. Wageningen, The Netherlands: PROSEA; 1997. pp. 223–225.
    1. Nakasone HY, Paull RE. Tropical Fruits. Walllingford, NY, USA: CAB International; 1998.
    1. Owoyele BV, Adebukola OM, Funmilayo AA, Soladoye AO. Anti-inflammatory activities of ethanolic extract of Carica papaya leaves. Inflammopharmacology. 2008;16(4):168–173.
    1. Gurung S, Škalko-Basnet N. Wound healing properties of Carica papaya latex: in vivo evaluation in mice burn model. Journal of Ethnopharmacology. 2009;121(2):338–341.
    1. Otsuki N, Dang NH, Kumagai E, Kondo A, Iwata S, Morimoto C. Aqueous extract of Carica papaya leaves exhibits anti-tumor activity and immunomodulatory effects. Journal of Ethnopharmacology. 2010;127(3):760–767.
    1. Imaga NA, Gbenle GO, Okochi VI, et al. Phytochemical and antioxidant nutrient constituents of Carica papaya and parquetina nigrescens extracts. Scientific Research and Essays. 2010;5(16):2201–2205.
    1. Halim SZ, Abdullah NR, Afzan Z, Abdul Rashid BA, Jantan I, Ismail Z. Acute toxicity of Carica papaya leaf extract in Sprague Dawley rats. Journal of Medicinal Plants Research. 2011;5(10):1867–1872.
    1. Ministry of Health of Malaysia. Vector borne disease control unit report, 2010.
    1. World Health Organization. Clinical diagnosis, 16, 2011.
    1. Kaur G, Jalagadugula G, Mao G, Rao AK. RUNX1/core binding factor A2 regulates platelet 12-lipoxygenase gene (ALOX12): studies in human RUNX1 haplodeficiency. Blood. 2010;115(15):3128–3135.
    1. Macaulay IC, Tijssen MR, Thijssen-Timmer DC, et al. Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins. Blood. 2007;109(8):3260–3269.
    1. Butkiewicz AM, Kemona H, Dymicka-Piekarska V, Matowicka-Karma J, Radziwon P, Lipska A. Platelet count, mean platelet volume and thrombocytopoietic indices in healthy women and men. Thrombosis Research. 2006;118(2):199–204.
    1. Dupont WD, Plummer WD. Power and sample size calculations: a review and computer program. Controlled Clinical Trials. 1990;11(2):116–128.
    1. Selisko B, Dutartre H, Guillemot JC, et al. Comparative mechanistic studies of de novo RNA synthesis by flavivirus RNA-dependent RNA polymerases. Virology. 2006;351(1):145–158.
    1. McRedmond JP, Park SD, Reilly DF, et al. Integration of proteomics and genomics in platelets: a profile of platelet proteins and platelet-specific genes. Molecular & Cellular Proteomics. 2004;3(2):133–144.
    1. Martins MA, Martins PM, Faria Neto HC, et al. Intravenous injections of PAF-acether induce platelet aggregation in rats. European Journal of Pharmacology. 1988;149(1-2):89–96.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe